Discover more from PsyMed Ventures Newsletter
What VCs Look for in Psychedelic Companies
Business Trip by PsyMed Ventures, a podcast about the business of psychedelics
Welcome back to Business Trip by PsyMed Ventures, a podcast about the business of psychedelics! 🍄
What does it take for a traditional VC to fund a psychedelic company? In our latest episode, Matias takes us behind the scenes of a panel discussion at the Psychedelic Therapeutics & Drug Development Conference in San Francisco, CA. Matias talks with VCs at firms with $100M+ fund sizes: Anne Dwane, a partner at Village Global, Amanda Way, principal at Jazz Venture Partners and Dana Watt PhD, principal at Breakout Ventures.
In this episode, we discuss:
How VCs identify and evaluate a strong founding team
Evaluating scientific, technical, and market risk
The pros and cons of platforms vs. asset companies
How to position a psychedelic company in the broader biotech ecosystem
About the VCs:
Village Global is a generalist early stage fund backed by some of the world’s most successful entrepreneurs. They invest in several industries and around 25% of their investments are in life sciences.
Jazz Venture Partners invests in companies at the convergence of technology, science and humanity. They are very highly experienced in healthcare, medical devices and wellness.
Breakout Ventures is a fund that invests in creative bioscience entrepreneurs harnessing the power of cells and computation to scale solutions in human health and sustainability.
Once you've finished the episode, we'd love to hear your thoughts! Tweet us at @psymedventures to share your views.
P.S. Do you know someone who would enjoy the Business Trip by PsyMed Ventures podcast? Feel free to share this newsletter by clicking the link below and hitting the ❤️ button on this post to help us reach more people on Substack 🙏
Business Trip by PsyMed Ventures is a podcast about psychedelic startups. Each episode features a new company in the field, ranging from biotech startups developing novel compounds, to clinics and retreats for healing, to software companies building tools to power the ecosystem.
Thanks for listening,